Your genetic code is unique. Your cancer treatment should be too.
Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives.
At Kura Oncology, we are committed to realizing the promise of precision medicines for the treatment of cancer.
We are advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
In The News
Biotech Strategy Blog: The Value of Biomarkers in Rescuing Oncology R&D
FirstWord Pharma: With KRAS in the spotlight, Kura takes on HRAS
Our Team
Meet some of the employees who make Kura such a great place to work.
Video
Targeting an Undruggable Oncogene: Tipifarnib and HRAS Mutant Tumors